| Literature DB >> 28515929 |
Tomoyuki Igarashi1, Keigo Okamoto1, Koji Teramoto2, Ryosuke Kaku1, Keiko Ishida1, Keiko Ueda1, Yo Kawaguchi1, Tetsuo Hori1, Masayuki Hashimoto1, Shoji Kitamura1, Noriaki Tezuka1, Jun Hanaoka1.
Abstract
Vertebral metastasis of non-small-cell lung cancer (NSCLC) often leads to neurological paralysis, with deterioration of the patients' activities of daily living (ADL). Surgical treatments for the symptoms are unlikely to be recommended due to the poor prognosis of patients with advanced NSCLC. The aim of the present study was to retrospectively evaluate the clinical outcome of posterior spinal fixation surgery in patients with neurological paralysis resulting from vertebral metastasis of NSCLC. Between April, 2007 and March, 2012, 4 patients (3 men and 1 woman; median age, 56.5 years) underwent fixation surgery at the Shiga University of Medical Science Hospital (Otsu, Japan). The mean preoperative Tokuhashi and Tomita scores of the patients were high (8.25 and 7.0, respectively). However, the Frankel grade functional score and performance status of the patients improved following fixation surgery, after which all patients received chemoradiotherapy. Postoperatively, the median paralysis-free time was 41 months (range, 17-42 months) and the median survival time was 42.5 months (range, 22-43 months). According to the functional scores, the patients had a poor prognosis, which may have been a contraindication for fixation surgery. In these cases, however, surgical treatment improved the patients' ADL and increased the likelihood of receiving anticancer therapy, contributing to the prolongation of survival. Therefore, fixation surgery may be beneficial for patients with neurological paralysis following vertebral metastasis of advanced NSCLC.Entities:
Keywords: Tokuhashi score; Tomita score; non-small-cell lung cancer; posterior fixation surgery; prognosis; skeletal-related events; vertebral metastasis
Year: 2017 PMID: 28515929 PMCID: PMC5431330 DOI: 10.3892/mco.2017.1199
Source DB: PubMed Journal: Mol Clin Oncol ISSN: 2049-9450